Page 5 - Steven Pfanstiel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Marinus Pharmaceuticals, Inc (NASDAQ:MRNS) CFO Sells $26,616 60 in Stock

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) CFO Steven Pfanstiel sold 2,790 shares of the business’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $9.54, for a total transaction of $26,616.60. Following the completion of the sale, the chief financial officer now owns 49,338 shares […]

United statesSteven pfanstielAmerican international group incMarinus pharmaceuticals incMarinus pharmaceuticals company profileMarinus pharmaceuticalsNews ratings for marinus pharmaceuticals dailyJennison associatesInternational biotechnology trustYork mellon corpMarinus pharmaceuticals price performanceGet free reportBiotechnology trustInternational groupNew york mellon corpMarinus pharmaceuticals daily

Marinus Pharmaceuticals, Inc (NASDAQ:MRNS) Q1 2023 Earnings Call Transcript

Operator: Greetings and welcome to the Marinus Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode.

District of columbiaUnited statesUnited arab emiratesPuerto ricoJoseph thomeSasha damouni ellisBrian abrahamsMark goodmanSteve pfanstielAlex aimettiDamouni ellisScott braunsteinChristy shaferCantor fitzgeraldMarvin johnsonRaj rajaraman

Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Finan

ZTALMY® U.S. net product revenue of $2.3 million for the fourth quarter of 2022 and $2.9 million for the fiscal year ended December 31, 2022Company expects ZTALMY U.S. net product revenues of between $15 million and $17 million for the fiscal year ending December 31, 2023Second generation oral formulation developmen.

District of columbiaUnited statesPuerto ricoSteven pfanstielSasha damouni ellisScott braunsteinCorporate affairs investor relationsMarinus pharmaceuticalsMarinuspharma marinus pharmaceuticals incTrademark officeCompany annual report on formCommittee for medicinal products human useBiomedical advanced researchHuman servicesUs department of healthAdministration for strategic preparedness

Form 8-K MARINUS PHARMACEUTICALS, For: Nov 07

Form 8-K MARINUS PHARMACEUTICALS, For: Nov 07
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSteven pfanstielCapital marketsHogan lovellsCommission file numberExchange commissionMarinus pharmaceuticalsCantor fitzgeraldRadnor corporate centerMarinus pharmaceuticals incSecurities exchangeWall streetCorporate centerZip codeSecurities actExchange act

Marinus Signs $32 5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners

Marinus Signs $32 5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United statesSteven pfanstielMarinus pharmaceuticalsSagard healthcare partners